• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Chemoradiotherapy vs. total laryngectomy for primary treatment of advanced laryngeal squamous cell carcinoma.

作者信息

Strojan Primož, Haigentz Missak, Bradford Carol R, Wolf Gregory T, Hartl Dana M, Langendijk Johannes A, Rinaldo Alessandra, Eisbruch Avraham, Mendenhall William M, Forastiere Arlene A, Takes Robert P, Ferlito Alfio

出版信息

Oral Oncol. 2013 Apr;49(4):283-6. doi: 10.1016/j.oraloncology.2012.11.002. Epub 2012 Dec 7.

DOI:10.1016/j.oraloncology.2012.11.002
PMID:23219843
Abstract
摘要

相似文献

1
Chemoradiotherapy vs. total laryngectomy for primary treatment of advanced laryngeal squamous cell carcinoma.同步放化疗与全喉切除术用于晚期喉鳞状细胞癌的初始治疗比较
Oral Oncol. 2013 Apr;49(4):283-6. doi: 10.1016/j.oraloncology.2012.11.002. Epub 2012 Dec 7.
2
Comparison of quality of life outcomes in laryngeal cancer patients following chemoradiation vs. total laryngectomy.喉癌患者接受放化疗与全喉切除术后生活质量结果的比较。
Otolaryngol Head Neck Surg. 2005 Jun;132(6):948-53. doi: 10.1016/j.otohns.2004.12.014.
3
Combined modality treatment of laryngeal squamous cell carcinoma.喉鳞状细胞癌的综合治疗
Expert Rev Anticancer Ther. 2007 Mar;7(3):331-50. doi: 10.1586/14737140.7.3.331.
4
[Combined radiosurgical treatment of cancer of the larynx (record of results obtained with 178 patients treatment at the Institut Gustave-Roussy, 1960-1964)].喉癌的联合放射外科治疗（古斯塔夫 - 鲁西研究所1960 - 1964年对178例患者治疗结果记录）
Ann Otolaryngol Chir Cervicofac. 1968 Oct-Nov;85(7):617-27.
5
Management of stage IV glottic carcinoma: therapeutic outcomes.IV期声门癌的治疗：治疗结果
Laryngoscope. 2004 Aug;114(8):1438-46. doi: 10.1097/00005537-200408000-00024.
6
Quality of Life After Conservation Surgery for Laryngeal Cancer.喉癌保喉手术后的生活质量。
Otolaryngol Clin North Am. 2015 Aug;48(4):655-65. doi: 10.1016/j.otc.2015.04.010. Epub 2015 Jun 17.
7
Controversies in the management of advanced laryngeal squamous cell carcinoma.晚期喉鳞状细胞癌治疗中的争议
Cancer. 2004 Jul 15;101(2):211-9. doi: 10.1002/cncr.20231.
8
Treatment of advanced carcinoma of the larynx. Review of 98 cases.晚期喉癌的治疗。98例病例回顾。
S Afr Med J. 1972 Nov 11;46(45):1733-7.
9
Larynx preservation.喉保留
Curr Opin Oncol. 2012 May;24(3):218-22. doi: 10.1097/CCO.0b013e3283523c95.
10
Carcinoma on the larynx and laryngopharynx. A report of 137 cases with particular reference to treatment by irradiation.喉癌和下咽癌。137例报告，特别提及放射治疗。
J Laryngol Otol. 1969 Jan;83(1):55-67.

引用本文的文献

1
Construction of a risk model associated with tryptophan metabolism and identification of related molecular subtypes in laryngeal squamous cell carcinoma.构建与色氨酸代谢相关的风险模型并鉴定喉鳞状细胞癌中的相关分子亚型
Front Genet. 2025 Mar 24;16:1530334. doi: 10.3389/fgene.2025.1530334. eCollection 2025.
2
IncRNA AC004943.2 regulates miR-135a-5p and PTK2/P13K axis to promote laryngeal squamous cell carcinoma progression.长链非编码RNA AC004943.2通过调控miR-135a-5p和PTK2/PI3K轴促进喉鳞状细胞癌进展。
J Cell Commun Signal. 2024 Feb 9;18(1):e12016. doi: 10.1002/ccs3.12016. eCollection 2024 Mar.
3
Survival in an era of organ preservation: an update on laryngeal cancer in Ireland.
在器官保存时代的生存：爱尔兰喉癌的最新进展。
Eur Arch Otorhinolaryngol. 2023 Oct;280(10):4587-4595. doi: 10.1007/s00405-023-08055-0. Epub 2023 Jun 16.
4
LncRNA-Associated ceRNA Network Reveals Novel Potential Biomarkers of Laryngeal Squamous Cell Carcinoma.LncRNA 相关 ceRNA 网络揭示了喉鳞状细胞癌的新型潜在生物标志物。
Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033820985787. doi: 10.1177/1533033820985787.
5
Patterns of Cervical Lymph Node Metastasis in Locally Advanced Supraglottic Squamous Cell Carcinoma: Implications for Neck CTV Delineation.局部晚期声门上型鳞状细胞癌颈部淋巴结转移模式：对颈部临床靶区勾画的意义
Front Oncol. 2020 Aug 27;10:1596. doi: 10.3389/fonc.2020.01596. eCollection 2020.
6
Transcriptome Analysis Identifies ALCAM Overexpression as a Prognosis Biomarker in Laryngeal Squamous Cell Carcinoma.转录组分析确定活化白细胞黏附分子过表达为喉鳞状细胞癌的预后生物标志物。
Cancers (Basel). 2020 Feb 18;12(2):470. doi: 10.3390/cancers12020470.
7
Organ Preservation Protocols in T4 Laryngeal Cancer: a Review of the Literature.T4期喉癌的器官保存方案：文献综述
Indian J Surg Oncol. 2019 Mar;10(1):149-155. doi: 10.1007/s13193-018-0840-9. Epub 2018 Dec 1.
8
Electrochemotherapy of radioresistant head and neck squamous cell carcinoma cells and tumor xenografts.电化学疗法治疗耐辐射头颈部鳞状细胞癌细胞和肿瘤异种移植物。
Oncol Rep. 2019 Mar;41(3):1658-1668. doi: 10.3892/or.2019.6960. Epub 2019 Jan 9.
9
miR-632 Promotes Laryngeal Carcinoma Cell Proliferation, Migration, and Invasion Through Negative Regulation of GSK3β.miR-632 通过负向调控 GSK3β 促进喉癌细胞的增殖、迁移和侵袭。
Oncol Res. 2020 Feb 7;28(1):21-31. doi: 10.3727/096504018X15213142076069. Epub 2018 Mar 21.
10
Utility of chemoradioselection for the optimization of treatment intensity in advanced hypopharyngeal and laryngeal carcinoma.放化疗选择在晚期下咽癌和喉癌治疗强度优化中的应用价值
Mol Clin Oncol. 2017 Dec;7(6):965-970. doi: 10.3892/mco.2017.1466. Epub 2017 Oct 20.